Samsung goes big on anti-glare screens and AI with 2025 TV lineup
The company’s “glare-free” display has proven divisive.
Related Articles
Medicaid Expansion Debate Will Affect Other Health Policy Issues Before Montana Legislature – KFF Health News
Legislative leaders say the decision whether to renew Montana’s Medicaid expansion program this year will loom over behavioral health spending and hospital regulation, among other…
Dry January: Should Doctors Make It Year-Round?
Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on booze? The answer is complicated.
Transcarent acquires Accolade for $621 million to create benefits tech giant
Transcarent CEO Glen Tullman spent much of 2024 hinting that his health benefits upstart might be shopping around for acquisitions, and just over a week
Study: Why Quick Fixes Don’t Work in Workplace Wellness – MedCity News
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits.
Senate report slams private equity in healthcare
Apollo Global Management and Leonard Green & Partners banked hundreds of millions while harming hospitals, according to a bipartisan report from the Senate Budget Committee.
What Is Norovirus?
This JAMA Patient Page describes the symptoms, diagnosis, treatment, and prevention of norovirus.
Morning Coffee Linked to Longer Life, Heart Health Benefits
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — For many, coffee is a beloved morning ritual, fueling the day ahead. But what if the time you…
Low back pain
Low back pain covers a spectrum of different types of pain (eg, nociceptive, neuropathic and nociplastic, or non-specific) that frequently overlap. The elements comprising the…
Study identifies risk potential for thousands of mutations of a cancer gene
Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure worried patients about their cancer risk…
Who would have won the Simon-Ehrlich bet over different decades, and what do long-term prices tell us about resource scarcity?
In the 1980s, economist Julian Simon won his bet with biologist Paul Ehrlich on mineral prices. But what does the long-term data tell us about…
